Synthesis of Uronic Acid 1-Azasugars as Putative Inhibitors of a-Iduronidase, b-Glucuronidase and Heparanase

25 October 2022, Version 1
This content is a preprint and has not undergone peer review at the time of posting.


1-Azasugar analogues of L-iduronic acid (L-IdoA) and D-glucuronic acid (D-GlcA) and their corresponding enantiomers were synthesized as potential pharmacological chaperones for mucopolysaccharidosis I (MPS I), a lysosomal storage disease caused by mutations in the gene encoding a-iduronidase (IDUA). The compounds were efficiently synthesized in nine or ten steps from D- or L-arabinose and the structures were confirmed by X-ray crystallographic analysis of key intermediates. All compounds were inactive against IDUA, although L-IdoA-configured 8 moderately inhibited b-glucuronidase (b-GLU). The D-GlcA-configured 9 was a potent inhibitor of b-GLU and a moderate inhibitor of the endo-b-glucuronidase heparanase. Co-crystallization of 9 with heparanase revealed that the endocyclic nitrogen of 9 forms close interactions with both the catalytic acid and catalytic nucleophile.


uronic acid 1-azasugars

Supplementary materials

Supporting Information
General methods Synthesis – experimental procedures Small molecule X-ray crystallographic studies Enzyme activity assays Heparanase-inhibitor X-ray crystallographic studies References Copies of NMR spectra


Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.
Comment number 1, Vito Ferro: May 20, 2024, 04:39

This has now been published in ChemBioChem 2023, 24, e202200619.